FDA staff finds Puma Biotech's cancer drug effective, shares soar
(Reuters) - Shares of Puma Biotechnology Inc surged about 80 percent on Monday after the U.S. Food and Drug Administration staffers concluded after a preliminary review that the company's experimental breast cancer drug was effective.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health